abstract |
(57) [Summary]nThe present invention relates to compounds that inhibit, modulate and / or alter tyrosine kinase signaling, compositions comprising said compounds, and tyrosine kinase dependent diseases and conditions in mammals such as angiogenesis, cancer, tumor growth, atherosclerosis The present invention relates to a method of using the above-mentioned compound for treating symptom, senile macular degeneration, diabetic retinopathy, inflammatory disease and the like. |